Foghorn Therapeutics (FHTX) Accumulated Expenses (2019 - 2026)
Foghorn Therapeutics' Accumulated Expenses came in at $7.96 million for Q2 2026, down 7.1% from $8.56 million a year earlier but up 15.0% from the prior quarter.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Foghorn Therapeutics' Accumulated Expenses was $11.36 million, up 33.1% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $8.53 million in FY2024 (-6.3%), $9.11 million in FY2023 (-17.2%), $11 million in FY2022 (+15.0%) and $9.56 million in FY2021 (+4.4%).
- The five-year range for quarterly Accumulated Expenses is $6.27 million (Q1 2024) to $11.36 million (Q4 2025).
- Year-over-year, Accumulated Expenses increased in five of the last eight quarters, with growth averaging 9.7%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2022 (growth of 57.1%), and the weakest in Q1 2024 (a decline of 29.1%).
- Business Quant data shows FHTX's Accumulated Expenses at $6.92 million (Q1 2026), $11.36 million (Q4 2025) and $9.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Foghorn Therapeutics | 209.61 Mn | -116.34 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.96 Mn |
| Mar 31, 2026 | 6.92 Mn |
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 8.56 Mn |
| Mar 31, 2025 | 6.45 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 11.22 Mn |
| Jun 30, 2024 | 6.45 Mn |
| Mar 31, 2024 | 6.27 Mn |
| Dec 31, 2023 | 9.11 Mn |
| Sep 30, 2023 | 8.80 Mn |
| Jun 30, 2023 | 8.14 Mn |
| Mar 31, 2023 | 8.83 Mn |
| Dec 31, 2022 | 11.00 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 7.01 Mn |
| Dec 31, 2021 | 9.56 Mn |
| Jun 30, 2021 | 5.15 Mn |
API Access
Foghorn Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();